ストックスクリーナーアプリを入手
33.05
2.77%
0.89
アフターアワーズ：
37.45
4.40
+13.31%
前日終値:
$32.16
開ける：
$32.01
24時間の取引高:
2.89M
Relative Volume:
2.00
時価総額：
$2.60B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.06%
1か月 パフォーマンス:
-31.03%
6か月 パフォーマンス:
-41.69%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$31.69
$33.57
1週間の範囲:
$30.08
$34.67
52週間の値動き範囲:
$30.08
$62.18
Hinge Health Inc Stock (HNGE) Company Profile
Compare HNGE vs VEEV, TEM, BTSG, HQY, DOCS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HNGE
Hinge Health Inc
|
33.05 | 2.53B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
186.99 | 30.35B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
55.88 | 10.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.34 | 7.17B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.35 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.24 | 5.08B | 550.17M | 201.35M | 232.07M | 1.00 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-09 | 開始されました | Wells Fargo | Overweight |
| 2025-09-05 | 開始されました | Robert W. Baird | Neutral |
| 2025-07-14 | 開始されました | Citizens JMP | Mkt Outperform |
| 2025-06-16 | 開始されました | Barclays | Overweight |
| 2025-06-16 | 開始されました | BofA Securities | Buy |
| 2025-06-16 | 開始されました | Canaccord Genuity | Buy |
| 2025-06-16 | 開始されました | Evercore ISI | Outperform |
| 2025-06-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-06-16 | 開始されました | Morgan Stanley | Overweight |
| 2025-06-16 | 開始されました | Needham | Buy |
| 2025-06-16 | 開始されました | Piper Sandler | Overweight |
| 2025-06-16 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-06-16 | 開始されました | Raymond James | Outperform |
| 2025-06-16 | 開始されました | Stifel | Buy |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-06-16 | 開始されました | William Blair | Outperform |
すべてを表示
Hinge Health Inc (HNGE) 最新ニュース
Hinge Health Reports Strong Q4 2025 Earnings with 46% Revenue Growth - Intellectia AI
Hinge Health reports fourth quarter and full year 2025 financial results - The National Law Review
Hinge Health Q4 2025 slides: 46% revenue growth, margins expand amid AI push - Investing.com
Earnings call transcript: Hinge Health Q4 2025 delivers strong earnings beat By Investing.com - Investing.com India
Hinge Health (NYSE:HNGE) Posts Quarterly Earnings Results - MarketBeat
Why Hinge Health, Inc. Class A Shares Are Sinking - TipRanks
Hinge Health soars as Q4 earnings triple estimates, outlook tops consensus - Investing.com India
(HNGE) Hinge Health Expects Full Year 2026 Revenue Range $732M$742M, vs. FactSet Est of $702.9M - marketscreener.com
Hinge Health Posts Record 2025 Results With Strong Profitability - TipRanks
(HNGE) Hinge Health, Inc. Expects Q1 Revenue Range $171.0M$173.0M - marketscreener.com
Hinge Health, Inc. options imply 9.7% move in share price post-earnings - TipRanks
Hinge Health earnings on deck as profitability test looms By Investing.com - Investing.com Canada
Hinge Health Inc (HNGE) Trading 2.57% Higher on Feb 10 - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Centene (CNC) - The Globe and Mail
Hinge Health (NYSE:HNGE) Sets New 52-Week LowShould You Sell? - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Jim Cramer Shed Light on These 19 Stocks Recently - Insider Monkey
Hinge Health (NYSE:HNGE) Sets New 1-Year LowHere's Why - MarketBeat
Jim Cramer Says Hinge Health Is “Going to Be One of the Better Stocks We’ve Seen in the Healthcare Sector” - Yahoo Finance
Physio App Maker Hinge Health, Backers Seek $437 Million IPO - MSN
Citizens reiterates Market Outperform rating on Hinge Health stock By Investing.com - Investing.com UK
Citizens reiterates Market Outperform rating on Hinge Health stock - Investing.com
Why Hinge Health Shares Are Sliding Despite Optimism - TipRanks
Hinge Health Inc. (NYSE:HNGE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Hinge Health Becomes Oversold (HNGE) - Nasdaq
Analyst Expectations For Hinge Health's Future - Benzinga
Analysts Conflicted on These Healthcare Names: Hinge Health, Inc. Class A (HNGE), Axsome Therapeutics (AXSM) and TG Therapeutics (TGTX) - The Globe and Mail
Freedom Capital Markets Initiates Coverage of Hinge Health (HNGE) with Buy Recommendation - Nasdaq
Canaccord Genuity reiterates Buy rating on Hinge Health stock ahead of earnings - Investing.com UK
Freedom Capital Markets initiates Buy on Hinge Health stock with $59 target - Investing.com
Canaccord Genuity reiterates Buy rating on Hinge Health stock ahead of earnings By Investing.com - Investing.com South Africa
Stifel reiterates Buy rating on Hinge Health stock citing MSK care gaps - Investing.com Nigeria
Stifel reiterates Buy rating on Hinge Health stock citing MSK care gaps By Investing.com - Investing.com South Africa
Hinge Health Inc (HNGE) Trading Down 3.2% on Jan 20 - GuruFocus
Will Hinge Health Inc. (HNGE) beat estimates again in its next earnings report? - MSN
Assessing Hinge Health (HNGE) Valuation As Shares Show Recent Uptick But Weak Broader Momentum - Yahoo Finance
Hinge Health’s 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care - Chartmill
Hinge Health (NYSE:HNGE) Trading Down 7.8%Here's What Happened - MarketBeat
Will Hinge Health Inc. (HNGE) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
San Bernardino Sun - FinancialContent
Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026 - Business Wire
Hinge Health: Strong Usage Momentum, Conservative Growth Expectations, and Competitive Moat Support Buy Rating - TipRanks
Hinge Health (NYSE:HNGE) Upgraded at Wells Fargo & Company - MarketBeat
Piper Sandler lowers Hinge Health stock price target to $60 from $71 - Investing.com Canada
Piper Sandler lowers Hinge Health stock price target to $60 from $71 By Investing.com - Investing.com South Africa
Hinge Health, Inc. Class A Common Stock (NY: HNGE - FinancialContent
HNGE Stock Coverage Initiated by Wells Fargo with Overweight Rat - GuruFocus
Hinge Health stock initiated with Overweight rating by Wells Fargo - Investing.com Australia
Hinge Health Inc (HNGE) 財務データ
Hinge Health Inc (HNGE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.88%
6.79%
大文字化:
|
ボリューム (24 時間):